Disease Risk: Mapping the emerging burden of dengue
The first nationally-representative survey of dengue has revealed the growing burden of the disease in Bangladesh.
- London School of Hygiene & Tropical Medicine, United Kingdom
Dengue is a viral disease spread by mosquitoes and found in more than 120 countries around the world (Bhatt et al., 2013). Because the species that transmits the disease, Aedes aegypti, lives in dense man-made environments, recent urbanization throughout the tropical world has accelerated the spread of dengue (Bhatt et al., 2013). Aedes aegypti is also the primary vector for a number of other diseases, including Zika, chikungunya and Yellow Fever, so understanding how to control the global emergence of dengue could help to prevent the spread of these diseases.
However, getting accurate data on who is being infected is surprisingly difficult. Only a small proportion of people (11–32%) are likely to have symptoms after contracting dengue, with few being sick enough to require formal medical care (Bhatt et al., 2013; Undurraga et al., 2013). And even if they receive medical care, misdiagnosis and under-reporting are common. This means that maps based on clinical case counts are not always useful, and may just reflect differences in access to healthcare, diagnostics and ability to report cases.
The gold standard for measuring who has been infected with dengue is a seroprevalence survey, where serum (blood) samples are taken from a representative group of people and tested for antibodies against the dengue virus. Now, in eLife, Henrik Salje and colleagues (who are based at institutes in France, the United States and Bangladesh) report how they have used this approach, which is usually reserved for local studies, on a scale never seen before to provide new insights into the transmission of dengue at a national level in Bangladesh (Salje et al., 2019).
Salje et al. visited 70 randomly selected communities across Bangladesh, between 2014 and 2016. During these visits, randomly selected residents were asked to contribute a blood sample and to answer a range of questions about behaviours thought to increase or decrease the risk of dengue. Overall, they found that 24% of participants showed evidence of previous dengue infection: this was much lower than the figures in other affected regions, such as Indonesia (~70%), where dengue has been around much longer (Tam et al., 2018). They also found that males were more likely to be infected than females, and that regular travellers were almost twice as likely to be infected as people who did not travel regularly.
However, the biggest factor in determining the risk of infection was location: over 80% of individuals in big cities, such as Dhaka, had been infected with the virus at some stage in their life, whereas fewer than 5% of people in rural areas showed signs of any previous infection. Using the results of their survey, Salje et al. were able to construct models that could predict seroprevalence in areas where data had not been collected, and then use this information to produce an updated risk map for dengue across Bangladesh (Figure 1).
Figure 1
Mapping dengue risk in Bangladesh.
A cross-sectional seroprevalence map (right) of dengue risk in Bangladesh, based on data collected from 70 communities throughout the country (Salje et al., 2019), shows that the risk is highest in the cities of Chittagong (in the south east), Khulna (south west) and Dhaka (in the middle of the country). Previous maps, such as this map based on data from Bhatt et al. (2013) (left), have predicted more widespread risk throughout the country, but these maps were largely based on less detailed data and often relied on extrapolation from nearby countries. This new study by Sajle et al. may suggest that there are unique, as yet unknown, factors that constrain the current distribution of dengue in Bangladesh.
By comparing seroprevalence between different age groups, Salje et al. were able to estimate the rate at which infections accumulate. Using standard 'catalytic models' (and making some assumptions about how long dengue has been in Bangladesh) they estimated that about 2.4 million people, out of a population of ~160 million, are infected with dengue virus in Bangladesh each year. In contrast fewer than 6,000 dengue cases per year were reported over the same time period, mostly in Dhaka (Mutsuddy et al., 2019). The results from this survey have the potential to play an important role in expanding and adapting dengue surveillance practices in Bangladesh.
Salje et al. also suggest that the current distribution of mosquito species in Bangladesh may be the cause of the limited spread of dengue. The mosquito that carries dengue, Aedes aegypti, was found in higher abundance in urban areas, whilst Aedes albopictus, a mosquito species that carries and transmits the virus less effectively, was more common in rural areas.
Together, these results paint a picture of a country part way through the emergence of dengue. Transmission is already high in urban centres but – unlike many countries in South East Asia and Latin America – regular, continuous transmission has yet to spread to more rural areas. However, more work is needed to understand how human movement and lower transmission potential in rural areas interact in shaping the current distribution of dengue in Bangladesh (Wesolowski et al., 2015). Genetic analyses of circulating dengue viruses can be used to identify the origins of outbreaks (Salje et al., 2017), which could help with efforts to contain the spread of the virus.
By proving the feasibility and value of nationally-representative seroprevalence surveys for dengue, it is hoped that the results of Salje et al. will renew interest in mass disease surveillance for dengue. Such community-representative surveys have proven instrumental for targeting and evaluating interventions for successful malaria control (Bhatt et al., 2015). A range of new dengue vaccines are currently becoming available, but some of these will only be beneficial if targeted to the areas of highest transmission (Flasche et al., 2016). Therefore, having regularly updated maps that accurately show the national spread of dengue will be critical in the ongoing fight against further expansion of the disease.
References
-
Dengue situation in Bangladesh: An epidemiological shift in terms of morbidity and mortalityCanadian Journal of Infectious Diseases and Medical Microbiology 2019:1–12.https://doi.org/10.1155/2019/3516284
-
Geographic variation in dengue seroprevalence and force of infection in the urban paediatric population of IndonesiaPLOS Neglected Tropical Diseases 12:e0006932.https://doi.org/10.1371/journal.pntd.0006932
-
Use of expansion factors to estimate the burden of dengue in Southeast Asia: A systematic analysisPLOS Neglected Tropical Diseases 7:e2056.https://doi.org/10.1371/journal.pntd.0002056
Article and author information
Author details
Publication history
- Version of Record published: May 13, 2019 (version 1)
Copyright
© 2019, Brady
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,928
- Page views
-
- 269
- Downloads
-
- 5
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Disease Risk: Mapping the emerging burden of dengue
eLife 8:e47458.
https://doi.org/10.7554/eLife.47458
Further reading
-
- Epidemiology and Global Health
Background:
Affectionate touch, which is vital for mental and physical health, was restricted during the Covid-19 pandemic. This study investigated the association between momentary affectionate touch and subjective well-being, as well as salivary oxytocin and cortisol in everyday life during the pandemic.
Methods:
In the first step, we measured anxiety and depression symptoms, loneliness and attitudes toward social touch in a large cross-sectional online survey (N = 1050). From this sample, N = 247 participants completed ecological momentary assessments over 2 days with six daily assessments by answering smartphone-based questions on affectionate touch and momentary mental state, and providing concomitant saliva samples for cortisol and oxytocin assessment.
Results:
Multilevel models showed that on a within-person level, affectionate touch was associated with decreased self-reported anxiety, general burden, stress, and increased oxytocin levels. On a between-person level, affectionate touch was associated with decreased cortisol levels and higher happiness. Moreover, individuals with a positive attitude toward social touch experiencing loneliness reported more mental health problems.
Conclusions:
Our results suggest that affectionate touch is linked to higher endogenous oxytocin in times of pandemic and lockdown and might buffer stress on a subjective and hormonal level. These findings might have implications for preventing mental burden during social contact restrictions.
Funding:
The study was funded by the German Research Foundation, the German Psychological Society, and German Academic Exchange Service.
-
- Epidemiology and Global Health
Background: Home-based self-sampling for human papillomavirus (HPV) testing may be an alternative for women not attending clinic-based cervical cancer screening.
Methods: We assessed barriers to care and motivators to use at-home HPV self-sampling kits during the COVID-19 pandemic as part of a randomized controlled trial evaluating kit effectiveness. Participants were women aged 30-65 and under-screened for cervical cancer in a safety-net healthcare system. We conducted telephone surveys in English/Spanish among a subgroup of trial participants, assessed differences between groups, and determined statistical significance at p<0.05.
Results: Over half of 233 survey participants reported that clinic-based screening (Pap) is uncomfortable (67.8%), embarrassing (52.4%), and discomfort seeing male providers (63.1%). The last two factors were significantly more prevalent among Spanish versus English speakers (66.4% vs. 30% (p=0.000) and 69.9 vs. 52.2% (p=0.006), respectively). Most women who completed the kit found Pap more embarrassing (69.3%), stressful (55.6%), and less convenient (55.6%) than the kit. The first factor was more prevalent among Spanish versus English speakers (79.6% vs. 53.38%, p=0.001) and among patients with elementary education or below.
Conclusions: The COVID-19 pandemic influenced most (59.5%) to participate in the trial due to fear of COVID, difficulty making appointments, and ease of using kits. HPV self-sampling kits may reduce barriers among under-screened women in a safety-net system.
Funding: This study is supported by a grant from the National Institute for Minority Health and Health Disparities (NIMHD, R01MD013715, PI: JR Montealegre).
Clinical trial number: NCT03898167.
